Cargando…

Usefulness of Aquaporin 1 as a Prognostic Marker in a Prospective Cohort of Malignant Mesotheliomas

(1) Background: Malignant mesothelioma (MM) is an aggressive tumour of the serosal membranes, associated with exposure to asbestos. Survival is generally poor, but prognostication for individual patients is difficult. We recently described Aquaporin 1 (AQP1) as independent prognostic factor in two s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Driml, Jack, Pulford, Emily, Moffat, David, Karapetis, Christos, Kao, Steven, Griggs, Kim, Henderson, Douglas Warrington, Klebe, Sonja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964417/ https://www.ncbi.nlm.nih.gov/pubmed/27376267 http://dx.doi.org/10.3390/ijms17071041

Ejemplares similares

Blockade of Aquaporin 1 Inhibits Proliferation, Motility, and Metastatic Potential of Mesothelioma In Vitro but not in an In Vivo Model
por: Klebe, Sonja, et al.
Publicado: (2015)

The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma
por: Pulford, Emily, et al.
Publicado: (2017)

Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
por: Pulford, Emily, et al.
Publicado: (2017)

BAP1 hereditary cancer predisposition syndrome: a case report and review of literature
por: Klebe, Sonja, et al.
Publicado: (2015)

Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis
por: Kirschner, Michaela B, et al.
Publicado: (2015)

An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma*
por: Klebe, Sonja, et al.
Publicado: (2016)

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma
por: Linton, A, et al.
Publicado: (2014)

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma
por: Linton, A, et al.
Publicado: (2018)

Comment on ‘Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'
por: Kao, S C-H, et al.
Publicado: (2014)

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
por: Tabata, Chiharu, et al.
Publicado: (2013)

Aurora Kinase A as a Diagnostic and Prognostic Marker of Malignant Mesothelioma
por: Guo, Zhenying, et al.
Publicado: (2021)

Aquaporin-6 May Increase the Resistance to Oxidative Stress of Malignant Pleural Mesothelioma Cells
por: Pellavio, Giorgia, et al.
Publicado: (2022)

Immunohistochemical Expression of Aquaporin-1 in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Report
por: Angelico, Giuseppe, et al.
Publicado: (2018)

Genetic Polymorphisms in Aquaporin 1 as Risk Factors for Malignant Mesothelioma and Biomarkers of Response to Cisplatin Treatment
por: Senk, Barbara, et al.
Publicado: (2019)

CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma
por: AMATYA, VISHWA JEET, et al.
Publicado: (2012)

Mutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant Mesothelioma
por: Lim, Chuan Bian, et al.
Publicado: (2013)

Study protocol of a phase 1 clinical trial establishing the safety of intrapleural administration of liposomal curcumin: curcumin as a palliative treatment for malignant pleural effusion (IPAL-MPE)
por: Hocking, Ashleigh Jean, et al.
Publicado: (2021)

Angiogenesis is an independent prognostic factor in malignant mesothelioma
por: Edwards, J G, et al.
Publicado: (2001)

Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma
por: HIRATA, TOMOMI, et al.
Publicado: (2015)

Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM)
por: Wright, Casey M., et al.
Publicado: (2013)

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma
por: Hudson, Amanda L., et al.
Publicado: (2014)

Clinical and Prognostic Features of Erionite-Induced Malignant Mesothelioma
por: Demirer, Ersin, et al.
Publicado: (2015)

Analysis of prognostic factors of patients with malignant peritoneal mesothelioma
por: Yin, Wenjie, et al.
Publicado: (2018)

Prognostic Value of EMT Gene Signature in Malignant Mesothelioma
por: Wu, Licun, et al.
Publicado: (2023)

Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma
por: Ebinç, Senar, et al.
Publicado: (2023)

Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin
por: Ak, Guntulu, et al.
Publicado: (2017)

Malignant mesothelioma
por: Ruffié, P, et al.
Publicado: (2001)

Malignant mesothelioma
por: Moore, Alastair J, et al.
Publicado: (2008)

Malignant mesothelioma
por: Ahmed, Ishtiaq, et al.
Publicado: (2013)

Malignant Mesothelioma
por: Pouliquen, Daniel L., et al.
Publicado: (2021)

The Significance of Short Latency in Mesothelioma for Attribution of Causation: Report of a Case with Predisposing Germline Mutations and Review of the Literature
por: Klebe, Sonja, et al.
Publicado: (2021)

Inhibitors of cytoskeletal dynamics in malignant mesothelioma
por: Reis, Katarina, et al.
Publicado: (2020)

HOX transcription factors are potential targets and markers in malignant mesothelioma
por: Morgan, Richard, et al.
Publicado: (2016)

miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma
por: Williams, Marissa, et al.
Publicado: (2015)

An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
por: Davis, Alexander, et al.
Publicado: (2022)

Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma
por: Meniawy, T M, et al.
Publicado: (2013)

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma
por: Štrbac, Danijela, et al.
Publicado: (2017)

Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report
por: Pezzuto, Federica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6itdsrj0rt6rqq1n4gnhasug8u